Home > Financial Ratios > JUBILANT PHARMOVA

JUBILANT PHARMOVA
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for JUBILANT PHARMOVA
Please provide your vote to see the results

JUBILANT PHARMOVA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 26.9219.03-30.24-17.43-10.80

What is the latest Core EBITDA Growth ratio of JUBILANT PHARMOVA ?

The latest Core EBITDA Growth ratio of JUBILANT PHARMOVA is 26.92 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202526.92
Mar202419.03
Mar2023-30.24
Mar2022-17.43
Mar2021-10.80

How is Core EBITDA Growth of JUBILANT PHARMOVA Trending?

Years Core EBITDA Growth % Change
Mar2025 26.92
41.46
Mar2024 19.03
Positive
Mar2023 -30.24
Negative
Mar2022 -17.43
Negative
Mar2021 -10.8 -

Other Financial Ratios of JUBILANT PHARMOVA


Compare Core EBITDA Growth ratio of peers of JUBILANT PHARMOVA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JUBILANT PHARMOVA ₹13,022.0 Cr -5.1% -15.3% -8.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,628.0 Cr -0.1% 4.7% 6.2% Stock Analytics
DIVIS LABORATORIES ₹167,975.0 Cr -1.7% 2.5% 12.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,804.0 Cr -1.1% 7.6% 45.4% Stock Analytics
DR REDDYS LABORATORIES ₹108,829.0 Cr -0.4% 6.3% 14.7% Stock Analytics
CIPLA ₹106,768.0 Cr -2.3% 0.3% -8.9% Stock Analytics


JUBILANT PHARMOVA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JUBILANT PHARMOVA

-5.1%

-15.3%

-8.5%

SENSEX

-4.1%

-5.8%

5.8%


You may also like the below Video Courses